Surging Flu Revenue Helps Inverness Post 3Q Profit

WALTHAM, Mass. (AP) ¿ Diagnostics company Inverness Medical Innovations Inc. said Tuesday it turned a profit in the third quarter as sales of flu tests jumped more than fivefold.

Inverness reported a profit of $14.3 million, or 17 cents per share. Leaving out one-time costs such as amortization, restructuring and stock-based compensation, it earned $66.6 million, or 74 cents per share. Inverness lost $9.1 million, or 12 cents per share, a year ago.

According to Thomson Reuters, analysts expected a profit of 61 cents per share, on average. Inverness shares set an annual high of $42.99 Tuesday. In afternoon trading they returned some of their earlier gains, but were still up 68 cents at $40.92.

The company said its net revenue climbed 22 percent to $535.8 million from $438.8 million. That included $40.4 million in North American flu product revenue, compared to $6.8 million a year ago. Inverness also reported $37.4 million in revenue from acquisitions, such as a diagnostic kit business it bought from ACON Laboratories in March, and its recent purchase of Concateno PLC.

Analysts had expected $491.7 million in revenue.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More from Technology

Amazon, Microsoft and Google Face Backlash over ICE, Military Deals

Amazon, Microsoft and Google Face Backlash over ICE, Military Deals

As Intel Loses Its CEO, How Well Can It Compete Against Nvidia?

As Intel Loses Its CEO, How Well Can It Compete Against Nvidia?

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists